Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.05.2015 | Case report

Regorafenib

Stevens Johnson syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Mihara Y, et al. Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma. Gan to Kagaku Ryoho 42: 233-236, No. 2, Feb 2015 [Japanese; summarised from a translation] - JapanPubMed Mihara Y, et al. Stevens-Johnson syndrome induced by regorafenib in a patient with progressive recurrent rectal carcinoma. Gan to Kagaku Ryoho 42: 233-236, No. 2, Feb 2015 [Japanese; summarised from a translation] - JapanPubMed
Metadaten
Titel
Regorafenib
Stevens Johnson syndrome: case report
Publikationsdatum
01.05.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-2027-2

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Tretinoin

Case report

Ticlopidine

Case report

Ruta

Case report

Prasugrel

Case report

Warfarin